Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 9

TABLE OF CONTENTS Volume 19, Issue 9 (September 2012) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement 2012 Annual Meeting of the International Society for Cell & Gene Therapy of Cancer Jointly Organised by ISCGT and National Cancer Centre Singapore 4-6 October 2012 @The Furama City Centre Singapore www.iscgt2012.com (Five Poster Prizes to be won, including the Beckman Poster Prize)   Original Articles Top Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review P Zarogoulidis, E Chatzaki, W Hohenforst-Schmidt, E P Goldberg, G Galaktidou, T Kontakiotis, N Karamanos and K Zarogoulidis Cancer Gene Ther 2012 19: 593-600; advance online publication, June 29, 2012; 10.1038/cgt.2012.36 Abstract | Full Text HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway Y Yao, Z-P Fang, H Chen, L Yue, D-l Min, L-N Tang, W-X Yu, H F Kung, M C Lin and Z Shen Cancer Gene Ther 2012 19: 601-608; advance online publication, July 6, 2012; 10.1038/cgt.2012.38 Abstract | Full Text Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype O A Issaenko, P B Bitterman, V A Polunovsky and P S Dahlberg Cancer Gene Ther 2012 19: 609-618; advance online publication, July 6, 2012; 10.1038/cgt.2012.39 Abstract | Full Text Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression K-J Zhang, J Zhang, Y-M Wu, J Qian, X-J Liu, L-C Yan, X-M Zhou, R-J Xiao, Y-G Wang, X Cao, N Wei, X-R Liu, B Tang, X-Y Jiao, K Chen and X-Y Liu Cancer Gene Ther 2012 19: 619-629; advance online publication, July 13, 2012; 10.1038/cgt.2012.40 Abstract | Full Text Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host Z Zhang, Z Hu, J Gupta, J D Krimmel, H M Gerseny, A F Berg, J S Robbins, H Du, B Prabhakar and P Seth Cancer Gene Ther 2012 19: 630-636; advance online publication, June 29, 2012; 10.1038/cgt.2012.41 Abstract | Full Text Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors R Omori, J Eguchi, K Hiroishi, S Ishii, A Hiraide, M Sakaki, H Doi, A Kajiwara, T Ito, M Kogo and M Imawari Cancer Gene Ther 2012 19: 637-643; advance online publication, July 13, 2012; 10.1038/cgt.2012.42 Abstract | Full Text Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells B-R Yi, K-A Hwang, N-H Kang, S U Kim, E-B Jeung, H-C Kim and K-C Choi Cancer Gene Ther 2012 19: 644-651; advance online publication, July 13, 2012; 10.1038/cgt.2012.45 Abstract | Full Text TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells M R Moniri, X-Y Sun, J Rayat, D Dai, Z Ao, Z He, C B Verchere, L-J Dai and G L Warnock Cancer Gene Ther 2012 19: 652-658; advance online publication, July 6, 2012; 10.1038/cgt.2012.46 Abstract | Full Text Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy H V Reddi, P Madde, S J McDonough, M A Trujillo, J C Morris, III, R M Myers, K W Peng, S J Russell, B McIver and N L Eberhardt Cancer Gene Ther 2012 19: 659-665; advance online publication, July 13, 2012; 10.1038/cgt.2012.47 Abstract | Full Text Advertisement Experimental & Molecular Medicine (EMM) Co-published with NPG from 2013! In January 2013, Nature Publishing Group will co-publish Experimental & Molecular Medicine (EMM), an official journal of the Korean Society for Biochemistry and Molecular Biology (KSBMB). EMM seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Discover more about EMM   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.